Alteplase drug class?

What drug class is alteplase in?

Alteplase is a thrombolytic (fibrinolytic) medicine. It belongs to the class of tissue plasminogen activators (tPA), a type of recombinant serine protease that helps break down fibrin clots by converting plasminogen to plasmin.[1]

What does that mean clinically (what is it used for)?

Because alteplase is a thrombolytic/tPA, it’s used to dissolve blood clots in conditions such as certain types of ischemic stroke and acute coronary or pulmonary thromboembolic events, depending on the indication and local protocol.[1]

How does alteplase compare with other “clot-busting” drugs?

Within the broader thrombolytic class, alteplase is specifically a tissue plasminogen activator (tPA). That distinguishes it from other thrombolytics that work through different activator mechanisms (for example, other fibrin-directed plasminogen activators).[1]

Is alteplase considered a biologic?

Alteplase is a recombinant protein (tPA), so it is generally treated as a protein biologic in how it’s manufactured and regulated, rather than as a small-molecule drug.[1]

Sources

[1] DrugPatentWatch.com – Alteplase (tPA) drug information: https://www.drugpatentwatch.com/